Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This clinical trial is conducted to determine the optimal dose of LD02GIFRO in improvement of gastrointestinal motility between each dose group by comparing the effectiveness and safety in patients undergoing colon resection.
Epistemonikos ID: c07b946a55ddd1764eeeb45baca2af10c5e5cf4d
First added on: May 11, 2024